Beta Bionics, Inc. Common Stock (BBNX) — Long-term Investment Intensity

Latest as of June 2026: 15.3%

Beta Bionics, Inc. Common Stock (BBNX) has a Long-term Investment Intensity of 15.3% as of June 2026. Long-term investments of $44.65 Million represent 15.3% of total assets of $292.39 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Beta Bionics, Inc. Common Stock (BBNX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

15.3%
LT Investments / Total Assets

Long-term Investments

$44.65 Million
USD

Total Assets

$292.39 Million
USD

Country

USA
NASDAQ

Beta Bionics, Inc. Common Stock Long-term Investment Intensity (2025–2025)

This chart shows how Beta Bionics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of June 2026, the intensity stands at 15.3%, reflecting long-term investments of $44.65 Million against total assets of $292.39 Million USD. For the complete balance sheet picture, see Beta Bionics, Inc. Common Stock balance sheet assets.

Annual Long-term Investment Intensity for Beta Bionics, Inc. Common Stock (2025–2025)

The table below presents the year-by-year Long-term Investment Intensity for Beta Bionics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Beta Bionics, Inc. Common Stock debt and liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 13.8% $45.43 Million $328.74 Million
pp = percentage points